BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 18, 2008
View Archived Issues
Human somatic cells can be induced into pluripotent stem cells without nuclear transfer
Read More
Neuroprotective effects of phosphorylated PRAS40 after spinal cord injury
Read More
New PPAR agonists described in recent patent
Read More
Novel diagnostic agents disclosed in recent patent from University of California, Oakland
Read More
Aastrom initiates patient treatment with stem cell therapy for dilated cardiomyopathy
Read More
Targeting the endothelin B receptor may improve the efficacy of tumor immune therapy
Read More
Intercell and PATH enter new collaboration for development of malaria vaccine
Read More
ActivBiotics extends deadline for sale of company assets until March 2008
Read More
Kamada announces completion of phase I studies with aerosolized alpha-1 antitrypsin
Read More
DelSite's nasal powder vaccine GelVac to move into phase I clinical trial later this year
Read More
Juvaris and Centers for Disease Control and Prevention enter agreement for H5N1 vaccine
Read More
Can-Fite expands studies to further investigate efficacy of CF-101 in treating uveitis
Read More
MAP completes SPA with FDA for phase III clinical trial of MAP-0004 for migraine
Read More
Cerimon initiates phase II/III trials of once-daily diclofenac sodium patch for pain
Read More
Novel treatment for spinal cord disorders reported in recent Sia Peptides patent
Read More
Denmark approves phase I clinical trials of PlGF antibody TB-403 in cancer
Read More
FDA approves ZymoGenetics' Recothrom commercialization
Read More
Schering-Plough files NDA for sugammadex in Japan
Read More
SGX announces that enrollment has begun in phase I clinical trials of SGX-523 for cancer
Read More
EPIX reports revised results from its phase IIa clinical trial of PRX-03140 in AD
Read More
XenoPort and GSK report top-line results for XP-13512 in the treatment of RLS
Read More
Shire launches Fosrenol in Spain, completing launch roll-out in E.U. markets
Read More
Dosing of Tracon's TRC-105 begins in cancer patients enrolled in a phase I trial
Read More